BravoVax Co., Ltd (BravoVax) is a "state level high-tech enterprise" established in the year 2012 and is specialized in the R&D, manufacturing and marketing of high quality human vaccines. In the span of six years, BravoVax has been awarded with various qualification and honors such as “Hubei Provincial Key Laboratory for New Vaccine and Recombinant Protein”, “Hubei Provincial Enterprise Technology Center”,"Provincial-level Bio-safety Laboratory”, "Gazelle Enterprise of Wuhan City” (an honor awarded to fast-growth hi-tech companies with bright prospect). BravoVax is also one of active members in Developing Country Vaccine Manufacturers Network (DCVMN) to provide the quality vaccines against infectious diseases. BravoVax is committed to the development, manufacturing and supply of human multivalent rotavirus vaccine and pneumococcal conjugate vaccine and strives to provide safe, effective and high quality vaccines for domestic and international markets.